% | $
Quotes you view appear here for quick access.

Anacor Pharmaceuticals, Inc. (ANAC) Message Board

  • imho_dyodd imho_dyodd Oct 20, 2013 2:08 PM Flag


    this company way overvalued. no revenue. 1 product will come to market next year....anothr in 2016/2017.

    the 1 product also does not seem very competitive to valean'ts(pre-NDA) and taro's novexatin(phase 2).

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • You are looking at PPS outside of market cap, potential, etc. a very rookie mistake or basher tactic. Look at ADHD its at 19 and has no product coming next year. ANAC will beat Valeant to market, with a drug that though less effective requires no surgical debris prior to use. We have a partnership with Bill Gates foundation to develop a specific drug, Now the U.S. Govt, as well. There are 7 other drugs in the works not including what Bill Gates and The U.S. Govt are asking them to develop.
      BioTech stocks trade on potential, not actual value. Its like the P/E on other stocks, and if you can't see the value in ANAC you should short it. I wish you the best (worst) in that.

114.415-9.445(-7.63%)1:05 PMEDT